Historical record - last NADAC effective date: 8/18/2021
Product Information
RIZATRIPTAN 5 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.5854 per EA under NDC 29300031621. Its NADAC has been published 138 times since Jan 2, 2019.
FDA first approved this application on Mar 7, 2017.
Strength
5 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300031621
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/18/2021
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA207836FDA Approved
3/7/2017
On Market Since
3/7/2017
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG TABLET has been published 138 times since Jan 2, 2019, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5854 per EA |
|---|---|
| All-time high | $1.0277 (Jan 15, 2020) |
| All-time low | $0.5528 (Jul 21, 2021) |
| Median price | $0.8061 |
| Average price | $0.8021 |
| Largest weekly change | -35.5% (Jul 21, 2021) |
| Weeks tracked | 138 |
| Tracking since | Jan 2, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-30.3%
Last surveyed Aug 18, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rizatriptan Benzoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.5854 per EA (NDC 29300031621), effective Aug 18, 2021.
How has the price of RIZATRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 30.3%. It has been tracked across 138 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?
Since Jan 2, 2019, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.5528 (Jul 21, 2021) to a high of $1.0277 (Jan 15, 2020), with a median of $0.8061 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3203 per EA — about 45% below RIZATRIPTAN 5 MG TABLET.
Who manufactures RIZATRIPTAN 5 MG TABLET?
RIZATRIPTAN 5 MG TABLET (NDC 29300031621) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.